in nearly 6 years only 3 dossiers submitted. Tropical drugs are...

in nearly 6 years only 3 dossiers submitted. Tropical drugs are much harder to develop. But hopefully attract double digit % returns. The other problem as stated last year is that because of Covid the FDA are down some 30% on issuing approvals so hopefully this year, years of development work gets submitted, hopefully 4 dossiers to the FDA, US first 1/4 reporting season hopefully Dash Pharma has some sales figures on our testosterone generic. Our Elma Cream generic can’t be that far from approval as we have Harris Pharma already waiting. Our Jublia Generic dossier seems to has stalled. But the main patient for Efinaconazole expires in October this year.